Literature DB >> 9687155

Repression of basal transcription by vitamin D receptor: evidence for interaction of unliganded vitamin D receptor with two receptor interaction domains in RIP13delta1.

P P Dwivedi1, G E Muscat, P J Bailey, J L Omdahl, B K May.   

Abstract

Repression of basal transcription of a 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) responsive 25-hydroxyvitamin D3-24-hydroxylase (CYP24) promoter construct as observed in kidney cells in the absence of ligand and this repression was dependent on a functional vitamin D response element (VDRE). Basal repression was also seen with a construct where a consensus DR-3-type VDRE was fused to the thymidine kinase promoter. Expression of a dominant negative vitamin D receptor (VDR) isoform that strongly bound to the VDRE motif in the CYP24 promoter ablated basal repression. This VDR isoform lacked sequence in the hinge- and ligand-binding domains implicating one or both of these domains in basal repression. It is well known that thyroid hormone and retinoic acid receptors silence basal transcription of target genes in the absence of ligands and this repressor function can be mediated by the nuclear receptor corepressor N-CoR. Two variants of N-CoR have been described, RIP13a and RIP13delta1. N-CoR and the variants contain two receptor interaction domains, ID-I and ID-II, which are identical except region ID-II in RIP13delta1 has an internal deletion. We have used the mammalian two hybrid system to investigate whether VDR, in the absence of ligand 1,25-(OH)2D3, can interact with these domains. The data showed that unliganded VDR does not interact with either ID-I or ID-II from RIP13a and RIP13delta1, but does interact strongly with a composite domain of ID-I and ID-II from RIP13delta1 (but not from RIP13a) and this strong interaction is abrogated in the presence of ligand. This finding implicates RIP13delta1 in VDR-dependent basal repression of the promoter constructs under investigation. However, over-expression of RIP13delta1 in kidney cell lines did not alter basal expression of the CYP24 promoter construct. It is concluded that either the level of endogenous RIP13delta1 in these kidney cells permits maximal repression or that repression occurs by a mechanism that is independent of RIP13delta1. Alternatively, repression may be dependent on RIP13delta1 but requires an additional cofactor that is limiting in these cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9687155     DOI: 10.1677/jme.0.0200327

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  15 in total

1.  The highly conserved region of the co-repressor Sin3A functionally interacts with the co-repressor Alien.

Authors:  Udo Moehren; Uwe Dressel; Christina A Reeb; Sami Väisänen; Thomas W Dunlop; Carsten Carlberg; Aria Baniahmad
Journal:  Nucleic Acids Res       Date:  2004-06-01       Impact factor: 16.971

2.  Estrogen down-regulation of the corepressor N-CoR: mechanism and implications for estrogen derepression of N-CoR-regulated genes.

Authors:  Jonna Frasor; Jeanne M Danes; Cory C Funk; Benita S Katzenellenbogen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-01       Impact factor: 11.205

3.  Functionality of unliganded VDR in breast cancer cells: repressive action on CYP24 basal transcription.

Authors:  Fatouma Alimirah; Avani Vaishnav; Michael McCormick; Ibtissam Echchgadda; Bandana Chatterjee; Rajendra G Mehta; Xinjian Peng
Journal:  Mol Cell Biochem       Date:  2010-05-04       Impact factor: 3.396

4.  Aldose Reductase Acts as a Selective Derepressor of PPARγ and the Retinoic Acid Receptor.

Authors:  Devi Thiagarajan; Radha Ananthakrishnan; Jinghua Zhang; Karen M O'Shea; Nosirudeen Quadri; Qing Li; Kelli Sas; Xiao Jing; Rosa Rosario; Subramaniam Pennathur; Ann Marie Schmidt; Ravichandran Ramasamy
Journal:  Cell Rep       Date:  2016-03-24       Impact factor: 9.423

Review 5.  Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations.

Authors:  Qiuhong Zhang; Beatriz Kanterewicz; Suzanne Shoemaker; Qiang Hu; Song Liu; Kristopher Atwood; Pamela Hershberger
Journal:  J Steroid Biochem Mol Biol       Date:  2012-09-28       Impact factor: 4.292

6.  Molecular action of 1,25-dihydroxyvitamin D3 and phorbol ester on the activation of the rat cytochrome P450C24 (CYP24) promoter: role of MAP kinase activities and identification of an important transcription factor binding site.

Authors:  Barbara K Nutchey; Josef S Kaplan; Prem P Dwivedi; John L Omdahl; Antonio Ferrante; Brian K May; Charles S T Hii
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

7.  Inhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cells.

Authors:  Wei Luo; Wei-Dong Yu; Yingyu Ma; Mikhail Chernov; Donald L Trump; Candace S Johnson
Journal:  Cancer Res       Date:  2013-01-28       Impact factor: 12.701

8.  Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor.

Authors:  Ji Young Kim; You Lee Son; Young Chul Lee
Journal:  Mol Endocrinol       Date:  2008-12-19

9.  Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers.

Authors:  Ruth Sánchez-Martínez; Alberto Zambrano; Ana I Castillo; Ana Aranda
Journal:  Mol Cell Biol       Date:  2008-03-24       Impact factor: 4.272

Review 10.  Mechanisms of transcription factor acetylation and consequences in hearts.

Authors:  Devi Thiagarajan; Srinivasan Vedantham; Radha Ananthakrishnan; Ann Marie Schmidt; Ravichandran Ramasamy
Journal:  Biochim Biophys Acta       Date:  2016-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.